OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
KPJH58

KPJ Healthcare Bhd

Healthcare Facilities & ServicesVerified

KPJ Healthcare Bhd maintains a debt-to-equity ratio of 1.44, indicating a moderate reliance on debt financing, and a current ratio of 1.52, suggesting adequate short-term liquidity to cover its obligations. The company's free cash flow of MYR 250.39 million reflects its ability to generate cash after capital expenditures, although the capital expenditure of MYR -277.35 million indicates ongoing investment in infrastructure. The company's profitability is reflected in a return on equity (ROE) of 13.27% and a return on assets (ROA) of 4.55%, which are key metrics for evaluating the efficiency of equity and asset utilization. These figures suggest that KPJ Healthcare Bhd is generating a solid return for its shareholders, although the ROA is relatively modest compared to the ROE, indicating that the company is leveraging debt to enhance returns. KPJ Healthcare Bhd's revenue is primarily concentrated in Malaysia, with no disclosed breakdown of geographic or segmental revenue distribution in the provided data. This lack of diversification may expose the company to regional economic and regulatory risks, although the absence of detailed segmental data limits a more granular assessment. The company's growth trajectory is supported by a positive operating cash flow of MYR 893.40 million and a net income of MYR 365.93 million, indicating a stable financial position. Analysts have provided a mean price target of MYR 3.32, with a median of MYR 3.25, suggesting a generally positive outlook for the stock. KPJ Healthcare Bhd faces a medium liquidity risk and a low dilution risk, with no significant dilution sources identified in the provided data. The company's risk assessment highlights a key flag of negative net cash after subtracting total debt, which may impact its financial flexibility. Recent events and filings have not been disclosed in the provided data, limiting the ability to assess any recent strategic or operational developments. However, the company's financial performance and analyst sentiment suggest a stable and potentially growing business.

30-day price · KPJH-0.10 (-3.1%)
Low$3.05High$3.51Close$3.15As of26 May, 00:00 UTC
Profile
CompanyKPJ Healthcare Bhd
TickerKPJH.KL
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. KPJ Healthcare Bhd operates in the healthcare facilities and services sector, providing medical services and pharmaceuticals to patients in Malaysia and potentially other markets.

Classification. KPJ Healthcare Bhd is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a confidence level of 0.92.

KPJ Healthcare Bhd maintains a debt-to-equity ratio of 1.44, indicating a moderate reliance on debt financing, and a current ratio of 1.52, suggesting adequate short-term liquidity to cover its obligations. The company's free cash flow of MYR 250.39 million reflects its ability to generate cash after capital expenditures, although the capital expenditure of MYR -277.35 million indicates ongoing investment in infrastructure. The company's profitability is reflected in a return on equity (ROE) of 13.27% and a return on assets (ROA) of 4.55%, which are key metrics for evaluating the efficiency of equity and asset utilization. These figures suggest that KPJ Healthcare Bhd is generating a solid return for its shareholders, although the ROA is relatively modest compared to the ROE, indicating that the company is leveraging debt to enhance returns. KPJ Healthcare Bhd's revenue is primarily concentrated in Malaysia, with no disclosed breakdown of geographic or segmental revenue distribution in the provided data. This lack of diversification may expose the company to regional economic and regulatory risks, although the absence of detailed segmental data limits a more granular assessment. The company's growth trajectory is supported by a positive operating cash flow of MYR 893.40 million and a net income of MYR 365.93 million, indicating a stable financial position. Analysts have provided a mean price target of MYR 3.32, with a median of MYR 3.25, suggesting a generally positive outlook for the stock. KPJ Healthcare Bhd faces a medium liquidity risk and a low dilution risk, with no significant dilution sources identified in the provided data. The company's risk assessment highlights a key flag of negative net cash after subtracting total debt, which may impact its financial flexibility. Recent events and filings have not been disclosed in the provided data, limiting the ability to assess any recent strategic or operational developments. However, the company's financial performance and analyst sentiment suggest a stable and potentially growing business.
Key takeaways
  • KPJ Healthcare Bhd maintains a strong ROE of 13.27%, indicating efficient use of equity capital.
  • The company's debt-to-equity ratio of 1.44 suggests a moderate level of leverage.
  • Analysts have a generally positive outlook, with a mean price target of MYR 3.32.
  • The company's liquidity position is adequate, with a current ratio of 1.52.
  • KPJ Healthcare Bhd's revenue concentration in Malaysia may expose it to regional risks.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyMYR
Revenue$4.26B
Gross profit$1.90B
Operating income$687.8M
Net income$365.9M
R&D
SG&A
D&A
SBC
Operating cash flow$893.4M
CapEx-$277.4M
Free cash flow$250.4M
Total assets$8.05B
Total liabilities$5.29B
Total equity$2.76B
Cash & equivalents
Long-term debt$3.96B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.76B
Net cash-$3.96B
Current ratio1.5
Debt/Equity1.4
ROA4.5%
ROE13.3%
Cash conversion2.4%
CapEx/Revenue-6.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Pharmaceuticals · cohort 779 companies
MetricKPJHActivity
Op margin16.2%7.7% medp25 -2.4% · p75 15.5%top quartile
Net margin8.6%5.9% medp25 -3.8% · p75 12.8%above median
Gross margin44.6%45.5% medp25 31.1% · p75 62.9%below median
R&D / revenue529.2% medp25 465.2% · p75 593.2%
CapEx / revenue-6.5%-7.0% medp25 -14.9% · p75 -3.2%above median
Debt / equity144.0%25.0% medp25 3.8% · p75 63.3%top quartile
Observations
IR observations
Mean price target3.32 MYR
Median price target3.25 MYR
High price target4.15 MYR
Low price target2.80 MYR
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count4.00
Buy count8.00
Hold count4.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.09 MYR
Last actual EPS0.08 MYR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-22 02:06 UTC#c868abd9
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 08:47 UTCJob: 0ab8fe5a